Gila Therapeutics
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $2.6M
Investors
- 2
About Gila Therapeutics
Based in Minnesota, US, and founded in 2014, Gila Therapeutics, Inc. operates as a biotechnology company that develops and provides pharmaceutical therapies for metabolic diseases. The biotech company has developed a lingual signaling PYY or Neural Signaling platform for the treatment of obesity, cardiometabolic disorders, type 2 diabetes, and associated metabolic disorders. The company’s therapeutic platform leverages a biological pathway to activate specific areas of the brain responsible for regulating food intake and metabolism via oral receptors, avoiding side effects such as nausea. As of August 2023, Gila has completed its Lingual PYY’s phase 1 trial and has multiple topical lingual hormone targets including GLP-1, amylin, leptin, etc. under development.
Who invested in Gila Therapeutics
2 investors across 3 rounds
See all investors in Gila Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gila Therapeutics
Who invested in Gila Therapeutics?
Gila Therapeutics has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gila Therapeutics raised?
Gila Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Gila Therapeutics last raise money?
Gila Therapeutics's most recent round on record is a Series A, in Mar 2023.
What does Gila Therapeutics do?
Based in Minnesota, US, and founded in 2014, Gila Therapeutics, Inc.
Where is Gila Therapeutics headquartered?
Gila Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Gila Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gila Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gila Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.